These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23551939)

  • 1. The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.
    Chu-Yuan H; Jing P; Yi-Sheng W; He-Ping P; Hui Y; Chu-Xiong Z; Guo-Jian L; Guo-Qiang W
    BMC Cancer; 2013 Apr; 13():177. PubMed ID: 23551939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of chemotherapy-associated hemoglobin on prognosis of colorectal cancer patients receiving adjuvant chemotherapy.
    Wei YS; Zhou YG; Wang GY; Liang ZH; Luo MR; Yang TA; Huang J
    Cancer Biomark; 2017 Dec; 20(4):627-635. PubMed ID: 28800321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Jia W; Yuan L; Ni H; Xu B; Zhao P
    Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
    Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
    Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer.
    Wei Y; Zhang X; Wang G; Zhou Y; Luo M; Wang S; Hong C
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e243-e251. PubMed ID: 29532611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer.
    Wu J; Ge XX; Zhu W; Zhi Q; Xu MD; Duan W; Chen K; Gong FR; Tao M; Shou LM; Wu MY; Wang WJ
    Mol Med Rep; 2019 Mar; 19(3):2330-2340. PubMed ID: 30664202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
    Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
    Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Chemotherapy-Induced Neutropenia in Stage III Colorectal Cancer.
    Kim S; Kang SI; Kim S; Kim JH
    J Surg Res; 2021 Nov; 267():391-396. PubMed ID: 34218138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of platelet count on prognosis of stage II-III colorectal cancer receiving adjuvant chemotherapy].
    Wei Y; Liang Z; Hong C; Luo D; Cai Z; Guan H; Zeng Z; Yang Z; Luo P; Tan Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Dec; 18(12):1261-4. PubMed ID: 26704012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adjuvant chemotherapy in stage II colorectal cancer patients.
    Lin HH; Chang YY; Lin JK; Jiang JK; Lin CC; Lan YT; Yang SH; Wang HS; Chen WS; Lin TC; Chang SC
    Int J Colorectal Dis; 2014 Oct; 29(10):1237-43. PubMed ID: 25024041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy.
    Yang J; Guo X; Wu T; Niu K; Ma X
    Medicine (Baltimore); 2019 Feb; 98(6):e14420. PubMed ID: 30732196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer.
    Roseweir AK; Park JH; Hoorn ST; Powell AG; Aherne S; Roxburgh CS; McMillan DC; Horgan PG; Ryan E; Sheahan K; Vermeulen L; Paul J; Harkin A; Graham J; Sansom O; Church DN; Tomlinson I; Saunders M; Iveson TJ; Edwards J
    J Pathol Clin Res; 2020 Oct; 6(4):283-296. PubMed ID: 32401426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
    Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
    Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
    Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
    Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
    Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer.
    Kozak MM; von Eyben R; Pai JS; Anderson EM; Welton ML; Shelton AA; Kin C; Koong AC; Chang DT
    Am J Clin Oncol; 2017 Aug; 40(4):405-412. PubMed ID: 25756348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.